{"SPADE_N_03126": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2007/0037744 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2007_0037744_A1", "Patent Type": "Patent Application", "Publication Date": "2007-2-15", "Family Info": "CN1878789A,US7718618,WO2005040192A2,WO2005040192A3,WO2005040201A1", "Patent Title": "Human cathelicidin antimicrobial peptides.", "Abstract": "Provided are peptide and peptide consensus sequences, which inhibit bacterial growth and/or viral growth and mimic the activity of LL-37, CRAMP, and/or FALL-39. The peptides are useful as antimicrobials, anti-inflammatories and anti-viral agents."}], "Sequence Information": {"SPADE ID": "SPADE_N_03126", "Peptide Name": "RK-31 (Derived from LL-37)", "Source": "Homo sapiens (Human sweat)", "Family": "Not found", "Gene": "Not found", "Sequence": "RKSKEKIGKEFKRIVQRIKDFLRNLVPRTES", "Sequence Length": 31, "UniProt Entry": "No entry found", "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-", "Antifungal"], "Target Organism": "[Ref.14978112]Gram-positive bacteria:Staphylococcus aureus mprF (MIC=8 µM), Staphylococcus aureus ATCC 25923 (MIC=16 µM), Group A Staphylococcus aureus (GAS) (MIC=8 µM);Gram-negative bacterium:Escherichia coli O29 (MIC=8 µM);Yeast:Candida albicans ATCC 14053 (MIC=4 µM).", "Hemolytic Activity": "[Ref.14978112]6% hemolytic activity at 44 μM against human erythrocytes", "Cytotoxicity": "Not included yet", "Binding Target": "Lipopolysaccharide (LPS)-binding", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C169H292N54O45", "Mass": 3800.46, "PI": 11.04, "Net Charge": 7, "Hydrophobicity": -1.16, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Function": "Has hemolytic activity against human erythrocytes .", "Literature": [{"Title": "Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense.", "Pubmed ID": "14978112", "Reference": "J Immunol 2004; 172 3070-3077.", "Author": "Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=14978112"}], "Frequent Amino Acids": "KRE", "Absent Amino Acids": "ACHMOUWY", "Basic Residues": 11, "Acidic Residues": 4, "Hydrophobic Residues": 10, "Polar Residues": 18, "Positive Residues": 11, "Negative Residues": 4, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02277", "Similarity": 1.0, "Sequence": "GDFFRKSKEKIGKEFKRIVQRIKDFLRN"}, {"SPADE_ID": "SPADE_N_03107", "Similarity": 1.0, "Sequence": "ALLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES"}, {"SPADE_ID": "SPADE_N_03128", "Similarity": 1.0, "Sequence": "LLGDFFRKSKEKIGKEFKRIVQR"}]}}}